Sudeep Pharma Limited (NSE:SUDEEPPHRM)
India · Delayed Price · Currency is INR 842.95
-9.55 (-1.12%)
Jun 19, 2026, 3:29 PM IST
Sudeep Pharma Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Sudeep Pharma stock has a consensus rating of "Sell" and an average price target of ₹663.50. The average 1-year stock price forecast is 21.29% lower than the current stock price, while the lowest is ₹627.00 (-25.62%) and the highest is ₹700.00 (-16.96%).
Price Target: ₹663.50 (-21.29%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Sudeep Pharma stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|
| Strong Buy | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 |
| Hold | 0 | 0 | 1 |
| Sell | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
7.40B
from 6.42B
Increased by 15.16%
Revenue Next Year
9.38B
from 7.40B
Increased by 26.82%
EPS This Year
17.10
from 15.50
Increased by 10.32%
EPS Next Year
19.35
from 17.10
Increased by 13.16%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 7.5B | |
| Avg | 7.4B | |
| Low | 7.3B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 17.0% | |
| Avg | 15.2% | |
| Low | 13.3% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 17.10 | |
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 10.3% | |
| Low | - |